Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Industry Meets With FDA On Mobile Health Regulatory Plan

This article was originally published in The Gray Sheet

Executive Summary

Members of the mHealth Regulatory Coalition hope their recent closed-door meeting with FDA will help lay the groundwork for clarifying which mobile health devices and software applications will face agency oversight.

Related Content

Attorneys, FDA Hit The Road To Instruct On Mobile Health Regs
mHealth Innovators Seek Access To More Wireless Spectrum
Medtronic Teams With Ford To Explore In-Vehicle Mobile Health Concepts
mHealth Insiders Differ On When Software Apps Should Face FDA Regs
Wireless and Mobile Monitoring: Bringing Health Care Home
Third Time's A Charm: Long Road To First 510(k)-Cleared Mobile Imaging App
Mobile Health In Brief
Shuren Sheds Light On Possible Regulation Of Mobile Health Apps
FDA, FCC Grapple With Regulation For Electronic Health Technologies
FDA Partners With FCC To Spur Wireless Health Technology Development





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts